Akari Therapeutics Plc (AKTX) Fell -9.22% or -0.17 To Price $1.63 On Thursday


Akari Therapeutics Plc (AKTX) fell -9.22% or -0.17 to $1.63. It is about 58491 shares traded, which is 293.28% compare to the average total volume 19944. The market cap of AKTX is $24.93 million. The year to date change is -68.22%. The 52 week price range is from $1.62 to $4.89. Price of AKTX have changed -0.26% during last week. It have changed -3.95% over last month, -13.05% over last 3 months, -5.94% over last 6 months and -61.05% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKTX is 1.87. It is 14.72% above current price. The 200-day Moving Averages for AKTX is 1.97. It is 20.86% above current price. The 52-week High is 4.89. It is 200.00% from the current price. The 52-week Low is 1.62. It is -0.61% from current price.

There are some statistics of AKTX. It is has market cap $24.93 million. The share outstanding is 15.26 million. The average volume is 19944. The percent of top 15 Institution holding is 11.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKTX is -261.01%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKTX is -143.99%.


Tags:

Share this post